ALX Oncology Holdings Inc. (ALXO)

Last Closing Price: 0.41 (2025-06-27)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

ALX Oncology Holdings Inc. (ALXO) Cost of Goods Sold data is not available for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-30.75M
Cost of Goods Sold
--
--
$31.82M
$-31.82M
$1.07M
$-30.75M
$-30.75M
$-30.75M
$-30.75M
$-30.75M
$-30.75M
$-31.82M
$-32.07M
53.36M
53.36M
$-0.58
$-0.58
Balance Sheet Financials
$102.53M
$2.70M
$18.37M
$120.90M
$18.74M
$8.23M
$13.86M
$32.60M
$88.30M
$88.30M
$88.30M
53.38M
Cash Flow Statement Financials
$-24.66M
$27.64M
$0.07M
$17.63M
$20.68M
$3.05M
$5.22M
--
--
Fundamental Metrics & Ratios
5.47
--
--
0.09
0.11
--
--
--
--
--
--
$-24.72M
--
--
--
--
--
--
--
-34.83%
-34.83%
-25.44%
-31.86%
$1.65
$-0.46
$-0.46